{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:06:59Z","timestamp":1792897619525,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jinf.2025.106472","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T20:51:18Z","timestamp":1741899078000},"page":"106472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Oral ADC189 for adults and adolescents with uncomplicated influenza"],"prefix":"10.1016","volume":"90","author":[{"given":"Jingya","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6152-2967","authenticated-orcid":false,"given":"Guoping","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0464-544X","authenticated-orcid":false,"given":"Jieming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2025.106472_bib1","unstructured":"World Health Organization: WHO. Influenza in the northern hemisphere is back. World Health Organization: WHO [Internet]; 2022 Oct 14. Available from: \u3008https:\/\/www.who.int\/news\/item\/14-10-2022-influenza-in-the-northern-hemisphere-is-back\u3009 [cited 2024 Oct 28]."},{"issue":"6","key":"10.1016\/j.jinf.2025.106472_bib2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/med.21401","article-title":"The influenza virus polymerase complex: an update on its structure, functions, and significance for antiviral drug design","volume":"36","author":"Stevaert","year":"2016","journal-title":"Med Res Rev"},{"issue":"10","key":"10.1016\/j.jinf.2025.106472_bib3","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/infdis\/jiac135","article-title":"Favipiravir treatment of uncomplicated influenza in adults: results of two phase 3, randomized, double-blind, placebo-controlled trials","volume":"226","author":"Hayden","year":"2022","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106472_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/infdis\/jiaa376","article-title":"A phase 2 study of pimodivir (JNJ-63623872) in combination with oseltamivir in elderly and nonelderly adults hospitalized with influenza a infection: OPAL Study","volume":"226","author":"O\u2019Neil","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2025.106472_bib5","unstructured":"Janssen to Discontinue Pimodivir Influenza Development Program. PR Newswire [Internet]; 2020 Sep 2. Available from: \u3008https:\/\/www.prnewswire.com\/news-releases\/janssen-to-discontinue-pimodivir-influenza-development-program-301122958.html\u3009 [cited 2024 Oct 28]."},{"issue":"5","key":"10.1016\/j.jinf.2025.106472_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(23)00743-0","article-title":"Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2025.106472_bib7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jinf.2025.106472_bib8","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(21)00469-2","article-title":"Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial","volume":"22","author":"Kumar","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2025.106472_bib9","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.12.1900170","article-title":"Influenza A (H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019","volume":"24","author":"Takashita","year":"2019","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.jinf.2025.106472_bib10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/cid\/ciz908","article-title":"Baloxavir marboxil in Japanese pediatric patients with influenza: safety and clinical and virologic outcomes","volume":"71","author":"Hirotsu","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2025.106472_bib11","article-title":"Inhibition of cap-dependent endonuclease in influenza virus with ADC189: a pre-clinical analysis and phase I trial","author":"Jing","year":"2025","journal-title":"Front Med"},{"issue":"6","key":"10.1016\/j.jinf.2025.106472_bib12","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2174\/0929867327666200114115632","article-title":"Insights into RNA-dependent RNA polymerase Inhibitors as antiinfluenza virus agents","volume":"28","author":"Giacchello","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jinf.2025.106472_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virusres.2017.01.013","article-title":"Structural insights into RNA synthesis by the influenza virus transcription-replication machine","volume":"234","author":"Pflug","year":"2017","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.jinf.2025.106472_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nsmb1212","article-title":"NMR-structure of an independently folded C-terminal domain of influenza polymerase subunit PB2","volume":"14","author":"Boudet","year":"2007","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"10.1016\/j.jinf.2025.106472_bib15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nsmb.1421","article-title":"Structure of the cap-binding domain of influenza virus polymerase subunit PB2 with bound m7GTP","volume":"15","author":"Guilligay","year":"2008","journal-title":"Nat Struct Mol Biol"},{"issue":"16","key":"10.1016\/j.jinf.2025.106472_bib16","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1128\/JVI.00600-06","article-title":"Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding","volume":"80","author":"Hara","year":"2006","journal-title":"J Virol"},{"issue":"7531","key":"10.1016\/j.jinf.2025.106472_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature14008","article-title":"Structure of influenza A polymerase bound to the viral RNA promoter","volume":"516","author":"Pflug","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jinf.2025.106472_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3851\/IMP3244","article-title":"Phase I study on safety and pharmacokinetics of a novel influenza endonuclease inhibitor, AL-794 (JNJ-64155806), following single- and multiple-ascending doses in healthy adults","volume":"23","author":"Kakuda","year":"2017","journal-title":"Antivir Ther"},{"issue":"2","key":"10.1016\/j.jinf.2025.106472_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/infdis\/jiy410","article-title":"Antiviral activity, safety, and pharmacokinetics of AL-794, a novel oral influenza endonuclease inhibitor: results of an influenza human challenge study","volume":"219","author":"Yogaratnam","year":"2018","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106472_bib20","article-title":"A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase","volume":"6","author":"Yuan","year":"2016","journal-title":"Sci Rep"},{"issue":"9218","key":"10.1016\/j.jinf.2025.106472_bib21","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jinf.2025.106472_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2025.106472_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2019.01.012","article-title":"Baloxavir marboxil in Japanese patients with seasonal influenza: dose response and virus type\/subtype outcomes from a randomized phase 2 study","volume":"163","author":"Watanabe","year":"2019","journal-title":"Antivir Res"},{"issue":"13","key":"10.1016\/j.jinf.2025.106472_bib24","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. GG167 Influenza Study Group","volume":"337","author":"Hayden","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jinf.2025.106472_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/irv.12788","article-title":"Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre-existing chronic respiratory disease: findings of a randomized, open-label study","volume":"15","author":"Kato","year":"2021","journal-title":"Influenza Other Respir Virus"},{"issue":"12","key":"10.1016\/j.jinf.2025.106472_bib26","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s40261-018-0710-9","article-title":"Safety, tolerability, and pharmacokinetics of the novel anti-influenza agent baloxavir marboxil in healthy adults: phase I study findings","volume":"38","author":"Koshimichi","year":"2018","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jinf.2025.106472_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coviro.2019.01.006","article-title":"Baloxavir marboxil: the new influenza drug on the market","volume":"35","author":"O\u2019Hanlon","year":"2019","journal-title":"Curr Opin Virol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:31:58Z","timestamp":1762248718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0163445325000660"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106472","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral ADC189 for adults and adolescents with uncomplicated influenza","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106472"}}